Showing results (21-30 of 53) with videos related to
Sort By:
Pageof 6
The Annals of Pharmacotherapy|March 22, 2007
Hospital policies for treatment of acute decompensated heart failureVikrant Vats, Robert J DiDomenico, Jeffrey E Wojtynek, et al.Pharmacotherapy|September 20, 2011
Comparison of rate control versus rhythm control for management of atrial fibrillation in patients with coexisting heart failure: a cost-effectiveness analysisAlexandra Perez, Daniel R Touchette, Robert J DiDomenico, et al.Cardiovascular Drugs and Therapy|August 2, 2019
Cost-Effectiveness of Strategies to Personalize the Selection of P2Y12 Inhibitors in Patients with Acute Coronary SyndromeKibum Kim, Daniel R Touchette, Larisa H Cavallari, et al.Chest|May 13, 2005
Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypassRobert J DiDomenico, Malek G Massad, Jacques Kpodonu, et al.Pharmacotherapy|March 27, 2013
Discharge counseling for patients with heart failure or myocardial infarction: a best practices model developed by members of the American College of Clinical Pharmacy's Cardiology Practice and Research Network based on the Hospital to Home (H2H) InitiativeBarbara S Wiggins, Jo E Rodgers, Robert J DiDomenico, et al.Pharmacotherapy|December 23, 2024
Disease-modifying therapies for amyloid transthyretin cardiomyopathy: Current and emerging medicationsErika L Hellenbart, Heather J Ipema, Mary C Rodriguez-Ziccardi, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 19, 2011
Selection of drug-laboratory result pairs for an inpatient asynchronous alert program: results of a Delphi surveyShengsheng Yu, William L Galanter, Robert J DiDomenico, et al.American Journal of Physiology. Heart and Circulatory Physiology|August 7, 2026
From Gut to Heart: The Emerging Role of Dietary Fermentable Fiber in Heart Failure with Preserved Ejection FractionFaisal Darbar, Medha Priyadarshini, Yueyang Wang, et al.Pharmacotherapy|December 24, 2019
Prevalence of Cardiac Risk Factors in Patients Prescribed Azithromycin before and after the 2012 FDA Warning on the Risk of Potentially Fatal Heart RhythmsHaridarshan Patel, Gregory Sampang Calip, Robert J DiDomenico, et al.Journal of Managed Care & Specialty Pharmacy|December 28, 2016
Contemporary Trends in Oral Antiplatelet Agent Use in Patients Treated with Percutaneous Coronary Intervention for Acute Coronary SyndromeKibum Kim, Todd A Lee, Daniel R Touchette, et al.Pageof 6